Schizophrenia - From Devilry to Disease
Abstract
Symptoms of psychotic diseases historically instilled fear and distrust in onlookers, who associated them with witchcraft, demonic spirits, and the devil. From Egyptian medicine to medieval witch hunts, psychotic diseases have been associated with the supernatural throughout history. Yet even with advancements in neuroscience and improvements in our understanding of mental illness, stigma surrounding mental health remains prevalent today. Schizophrenia is a psychiatric illness which has evaded a clinical definition until relatively recently; even now, the precise features that constitute a schizophrenic patient are open to dispute. This article explores the ancient history of mental health with a particular emphasis on psychosis, and also considers the changing attitudes and understanding of schizophrenia throughout the last century, leading to its clinical definition as a treatable condition.
References
2. Fusar-Poli P, Politi P. Paul Eugen Bleuler and the birth of schizophrenia (1908). Am J Psychiatry. 2008 Nov;165(11):1407. DOI: 10.1176/appi.ajp.2008.08050714.
3. Kyziridis TC. Notes on the history of schizophrenia. German J Psych. 2005;8:42-8.
4. Bryan CP, editor/translator. Chapter XX: The heart and circulatory system. In: The Papyrus Ebers. Letchworth, UK: The Garden City Press; 1930. pp. 124-32.
5. Bloomfield M, editor/translator. Chapter 1: Charms to cure disease and possession by demons of disease (Bhaishagykni). In: Hymns of the Atharva-Veda. Oxford, UK: Clarendon Press; 1897. pp. 1-48.
6. Veith I, editor/translator. Chapter 1: Introduction to the Nei Ching. Huang Ti Nei Ching Su Wen. The Yellow Emperor’s Classic of Internal Medicine. Berkeley, CA, USA: University of California Press; 1966:1-75.
7. Hippocrates, Jones WHS, translator. Hippocrates. Volume II. London, UK: Heinemann; 1923. p. 175.
8. Sarton G. Galen of Pergamon. Lawrence, KS, USA: University of Kansas Press; 1954. pp. 39-60.
9. Baas JH. Outlines of the History of Medicine and the Medical Profession. Volume II. Huntington, NY, USA: Robert E. Krieger Publishing Co.; 1971. pp. 359-61.
10. Lindemann M. Medicine and Society in Early Modern Europe. Cambridge, UK: Cambridge University Press; 1999. pp. 66-91,123-129.
11. Briggs R. Witches and Neighbours: The Social and Cultural Context of European Witchcraft. Oxford, UK: Blackwell; 2002. p. 19.
12. Almond P. Introduction. In: Demonic Possession and Exorcism in Early Modern England. Cambridge, UK: Cambridge University Press; 2004. pp. 1-42.
13. Kraepelin E. Chapter 7: Fundamental states. In: Manic-Depressive Insanity and Paranoia. Barclay RM, translator. Edinburgh, UK: E. & S. Livingstone; 1921. pp. 118-32.
14. Ackerknecht EH. A Short History of Psychiatry. Sulammith Wolff, translator. New York, NY, USA: Hafner Publishing Company; 1959. pp. 65-70,89-93.
15. Bleuler E. Dementia Praecox or the Group of Schizophrenias. New York, NY, USA: International Universities Press; 1955: pp. 227-244.
16. Southard EE, Noll R. Non-dementia non-praecox: note on the advantages to mental hygiene of extirpating a term [1919]. Hist Psychiatry. 2007 Dec;18(72 Pt 4):483-502. DOI: 10.1177/0957154X07082895.
17. Bleuler E, Zinkin J, translator. Dementia Praecox or the Group of Schizophrenias. New York, NY, USA: International Universities Press; 1950. pp. 3-12.
18. Dziegielewski SF. DSM-IV-TR in Action. Hoboken, NJ, USA: John Wiley & Sons; 2010. pp. 248-81.
19. Heyman A, Patterson JL Jr, Nichols FT Jr. The effects of induced fever on cerebral functions in neurosyphilis. J Clin Invest. 1950 Oct;29(10):1335-41. DOI: 10.1172/JCI102370.
20. Raichle ME. Functional neuroimaging: a historical and physiological perspective. In: Cabeza R, Kingstone A, editors. Handbook of Functional Neuroimaging of Cognition. 2nd edition. Cambridge, MA, USA: MIT Press; 2006. pp. 4-7.
21. Ross C, Read J. Chapter 9: Antipsychotic Medication: Myths and Facts. In: Read J, Mosher L, Bentall R, editors. Models of Madness: Psychological, Social and Biological Approaches to Schizophrenia. Brunner-Routledge: Hove, UK: 2004. pp. 101-3.
22. Joint Formulary Committee. British National Formulary, 67th edition. BMJ Group and Pharmaceutical Press: London. UK, 2014.
23. Kotrla KJ, Weinberger DR. Brain imaging in schizophrenia. Annu Rev Med. 1995;46:113-22. DOI: 10.1146/annurev.med.46.1.113.
24. Birchwood M, Jackson C. Chapter 3: Biological Aspects. In: Schizophrenia. Hove, UK: Psychology Press; 2001. pp. 35-61.
This is an Open Access journal. All material is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) licence, unless otherwise stated.
Please read our Open Access, Copyright and Permissions policies for more information.
